Tag: Novartis

Symjepi

Symjepi, the Auto-Injector Alternative, to Launch Q1 2019

Prefilled syringe will join auto-injectors for emergency delivery of epinephrine.
Xolair (omalizumab)

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Symjepi

Symjepi Back on Track After Adamis Finds Commercialization Partner

Partnership paves way for introduction of device already approved by the FDA.

Connect with Us

38,092FansLike
569FollowersFollow
2,651FollowersFollow
5,440FollowersFollow
38SubscribersSubscribe